About Novalar Pharm
Novalar Pharm is a company based in Manchester (United Kingdom) founded in 2000. Novalar Pharm has raised $53.23 million across 5 funding rounds from investors including NEA, Domain Associates and SR One. Novalar Pharm operates in a competitive market with competitors including Pharmacy2U, LloydsDirect, Health & Her, Chemist Direct and Chemist4U, among others.
- Headquarter Manchester, United Kingdom
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
- Legal Name Novalar (Uk) Limited
- Date of Incorporation 27 Mar, 2009
- Jurisdiction ALLINGTON, MAIDSTONE, KENT
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Total Equity Funding
$53.23 M (USD)
in 5 rounds
-
Latest Funding Round
$1 M (USD), Series D
Jul 23, 2010
-
Investors
NEA
& 3 more
-
Employee Count
Not available
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Funding Insights of Novalar Pharm
Novalar Pharm has successfully raised a total of $53.23M across 5 strategic funding rounds. The most recent funding activity was a Series D round of $1 million completed in July 2010. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in Novalar Pharm
Novalar Pharm has secured backing from 4 investors, including venture fund investors. Prominent investors backing the company include NEA, Domain Associates and SR One.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Venture capital investments are offered to startups by NEA.
|
Locked | Locked | Locked | |
|
Life science & tech focused VC firm investing in the US
|
Locked | Locked | Locked | |
|
A biotechnology venture capital firm investing in innovative science.
|
Locked | Locked | Locked |
Investor details for Novalar Pharm
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Novalar Pharm
Investment portfolio details for Novalar Pharm
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Novalar Pharm
Detailed financials for Novalar Pharm
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Novalar Pharm Comparisons
Peer comparison for Novalar Pharm
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Novalar Pharm
Novalar Pharm operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Pharmacy2U, LloydsDirect, Health & Her, Chemist Direct and Chemist4U, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Online pharmacy and teleconsultation platform
|
|
| Locked | Locked | Locked |
Prescription medicines are ordered and delivered via an online platform.
|
|
| Locked | Locked | Locked |
Women's health products and symptom tracking tools are provided online.
|
|
| Locked | Locked | Locked |
Online pharmacy store
|
|
| Locked | Locked | Locked |
Prescription medicines and health products are sold online by Chemist4U.
|
Detailed competitors of Novalar Pharm
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Novalar Pharm
Complete news archive for Novalar Pharm
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Novalar Pharm
Novalar Pharm was founded in 2000 and raised its 1st funding round 2 years after it was founded.
Novalar Pharm is headquartered in Manchester, United Kingdom. It is registered at Manchester, Greater Manchester, United Kingdom.
Novalar Pharm is a funded company, having raised a total of $53.23M across 5 funding rounds to date.
Novalar Pharm was established in 2000 in Manchester, United Kingdom, within the pharmaceutical sector. Operations are conducted as an online pharmacy, where a range of medicines is distributed across categories such as allergies, anti-infectives, diabetes, womens health, weight loss, and cardiovascular diseases. The platform serves customers digitally, with oversight from executives including CFO Robert Steven Stefanovich. Services focus on accessible medication procurement without physical storefronts.
Novalar Pharm's top competitors include Pharmacy2U, Health & Her and LloydsDirect.
Novalar Pharm has 4 investors. Key investors include NEA, Domain Associates, SR One, and Montreux Equity Partners.